A detailed history of Aqr Capital Management LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 187,561 shares of TWST stock, worth $7.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
187,561
Previous 61,428 205.33%
Holding current value
$7.92 Million
Previous $3.03 Million 179.95%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.72 - $58.88 $4.63 Million - $7.43 Million
126,133 Added 205.33%
187,561 $8.47 Million
Q2 2024

Aug 14, 2024

BUY
$27.95 - $53.0 $783,354 - $1.49 Million
28,027 Added 83.91%
61,428 $3.03 Million
Q1 2024

May 15, 2024

BUY
$32.28 - $41.5 $1.08 Million - $1.39 Million
33,401 New
33,401 $1.15 Million
Q2 2023

Aug 14, 2023

SELL
$11.49 - $20.46 $13,810 - $24,592
-1,202 Reduced 10.08%
10,727 $219,000
Q1 2023

May 15, 2023

BUY
$14.6 - $30.9 $174,163 - $368,606
11,929 New
11,929 $179,000
Q1 2022

May 16, 2022

SELL
$38.58 - $83.27 $134,374 - $290,029
-3,483 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$75.47 - $135.88 $890,017 - $1.6 Million
-11,793 Reduced 77.2%
3,483 $270,000
Q3 2021

Nov 15, 2021

BUY
$95.64 - $131.48 $151,493 - $208,264
1,584 Added 11.57%
15,276 $1.63 Million
Q2 2021

Aug 16, 2021

BUY
$88.13 - $142.06 $158,722 - $255,850
1,801 Added 15.15%
13,692 $1.82 Million
Q1 2021

May 17, 2021

BUY
$105.48 - $207.97 $494,595 - $975,171
4,689 Added 65.11%
11,891 $1.47 Million
Q4 2020

Feb 16, 2021

BUY
$76.64 - $167.89 $170,524 - $373,555
2,225 Added 44.71%
7,202 $1.02 Million
Q3 2020

Nov 16, 2020

BUY
$45.46 - $78.79 $226,254 - $392,137
4,977 New
4,977 $378,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.38B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.